AstraZeneca Explores Bristol Myers Squibb Acquisition

AstraZeneca has reportedly explored acquiring Bristol Myers Squibb in what would be a major pharmaceutical industry merger. Sources indicate that discussions may or may not be ongoing, and it remains uncertain whether the talks will lead to an actual transaction. Both companies have declined to comment on the potential deal.